A women's health issue: Alzheimer's disease and strategies for maintaining cognitive health

International Journal of Fertility and Women's Medicine

Volumn 44, Issue 4, 1999, Pages 174-185

  Brinton, Roberta Diaz ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Anti inflammatories; Antioxidants; Estrogen replacement therapy; Learning and memory

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; CONJUGATED ESTROGEN; DICLOFENAC; EQUILIN; ESTRADIOL; ESTROGEN; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PIROXICAM; PIRPROFEN; PREDNISONE; SULINDAC; TIAPROFENIC ACID; TOLFENAMIC ACID;

AGING; ALZHEIMER DISEASE; COGNITION; DISEASE PREDISPOSITION; DRUG EFFECT; ESTROGEN THERAPY; EXERCISE; FEMALE; HUMAN; LEARNING; MEMORY; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

AGED; ALZHEIMER DISEASE; COGNITION DISORDERS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; PRIMARY PREVENTION; PROGNOSIS; WOMEN'S HEALTH;

EID: 0032875858     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Brinton RD, Yamazaki RS: Advances and challenges in the prevention and treatment of Alzheimer's disease. Pharm Res 15:384-397, 1998.
2. Whitehouse PJ: Alzheimer's Disease: An international public health problem - Clinical goals, strategies, and outcomes, in Brioni JD, Decker MW (eds): Pharmacological Treatment of Alzheimer's Disease. Wiley-Liss, New York, pp 331-343, 1997.
3. Birge SJ: The role of estrogen in the treatment of Alzheimer's disease. Neurology 48(5):S36-S41, 1997.
4. Aronson MK, Ooi WL, Morgenstern H, et al: Women, myocardial infarction and dementia in the very old. Neurology 40:1102-1106, 1990.
5. Henderson VW: Estrogen replacement therapy for the prevention and treatment of Alzheimer's disease. CNS Drugs 8:343-351, 1997.
6. Solodkin S, Van Hoesen GW: Neuropathology and functional anatomy of Alzheimer's disease, in Brioni JD, Decker MW (eds): Pharmacological Treatment of Alzheimer's Disease. Wiley-Liss, New York, pp 151-177, 1997.
7. Snowdon DA, Greiner LH, Mortimer JA, et al: Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA 277(10):813-817, 1997.
8. Brinton RE: Biochemistry of learning & memory, in Martinez JL, Kesner RP (eds): Learning & Memory: A Biological View. Academic Press, San Diego, 2nd edition, pp 199-246, 1991.
9. Greenough WT, Larson JR, Withers GS: Effects of unilateral and bilateral training in a reaching task on dendritic branching of neurons in the rat motor-sensory forelimb cortex. Behav Neural Biol 44:301-314, 1985.
10. Brinton RD, Tran J, Proffitt P, et al: 17β-Estradiol increases the growth and survival of cultured cortical neurons. Neurochem Res 22(11):1339-1351, 1997.
11. Phillips SM, Sherwin BB: Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17:485-495, 1992.
12. Sherwin BB, Tulandi T: "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin releasing hormone agonist in women with leiomyomata uteri [see Comments]. J Clin Endocrinol Metabol 81:2545-2549, 1996.
13. Kampen DL, Sherwin BB: Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 83:979-983, 1994.
14. Lobo RA: Benefits and risks of estrogen replacement therapy. Am J Obstet Gynecol 173:982-989, 1995.
15. Brinton RD: Estrogen replacement therapy and Alzheimer's disease: How it could protect against cognitive decline and disease in postmenopausal women. Menopausal Med 5(1):5-9, 1997.
16. Tang MX, Jacobs D, Stern Y, et al: Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348:429-432, 1996.
17. Brinton RD, Proffitt P, Tran J, et al: Equilin, a principal component of the estrogen replacement therapy, Premarin, increases the growth of cortical neurons via an NMDA receptor dependent mechanism. Exp Neurol 147(2):211-220, 1997.
18. Shumaker S, Rapp S: Hormone replacement therapy in dementia prevention: The Women's Health Initiative Memory Study. Neurobiol Aging 17(4S):34, 1996.
19. Fillet H: Observations in a preliminary open trial of estradiol therapy for senile dementia - Alzheimer's type. Ann NY Acad Sci 743:233-239, 1994.
20. Brinton RD: Estrogen induction of rapid changes in the growth of cultured hippocampal nerve cells. Mol Cell Neurosci 4:36-46, 1993.
21. Brinton RD, Montoya M, Hsieh D: Premarin increases the growth of neurons from the cerebral cortex. Soc Neurosci Abst 22:299.3, 1996.
22. Luine VN: Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89:484-490, 1985.
23. Schneider LS, Farlow MK, Henderson VW, et al: Effects of estrogen replacement in patients with Alzheimer's disease. (in press).
24. Schneider LS, Farlow MK, Henderson VW, et al: Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology 46:1580-1584, 1996.
25. Singh M, Meyer EM, Millard WJ, Simpkins JW: The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 136(5):2320-2324, 1995.
26. Toran-Allerand CD, Miranda RC, Benthamn WD, et al: Estrogen receptors colocalize with low affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 89:4668-4672, 1992.
27. Brinton RD, Muhammad M, Hsieh D, et al: The estrogen replacement therapy, Premarin, increases neuronal survival and protects neurons against oxidative damage: Implications for Alzheimer's Disease. Soc Neurosci Abst 23:20.5, 1997.
28. Behl C, Skutella T, Lezoualc'h F, et al: Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol Pharmacol 51:535-541, 1997.
29. Goodman Y, Bruce AJ, Cheng B, et al: Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 66(5):1836-1844, 1996.
30. Green PS, Gridley KE, Simpkins JW: Estrogen receptor-independent neuroprotection by estratrienes: A novel interaction with glutathione. Neuroscience 84(1):7-10, 1998.
31. Green PS, Gordon K, Simpkins JW: Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Biol 63(4-6):229-235, 1997.
32. Paech K, Webb P, Kuiper GGJM, et al: Differential, ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277:1508-1510, 1997.
33. McGeer PL, Rogers J: Anti-inflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 42:447-449, 1992.
34. McGeer PL, Rogers J, McGeer EG: Neuroimmune mechanisms in Alzheimer disease pathogenesis. Alzheimer Dis Assoc Disord 8(3):149-158, 1994.
35. McGeer PL, McGeer E, Rogers J, et al: Anti-inflammatory drugs and Alzheimer disease. Lancet 335:1037, 1990.
36. Breitner JCS: The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu Rev Med 47:401-411, 1996.
37. Breitner JCS, Welsh KA, Plassman BL, et al: Inverse association of anti-inflammatory treatments and Alzheimer's disease: Initial results of a co-twin control study. Neurology 44:227-231, 1994.
38. Breitner JCS: Inflammatory processes and antiinflammatory drugs in Alzheimer's disease: A current appraisal. Neurobiol Aging 17(5):789-794, 1996.
39. Insel PS: Analgesic-antipyretics and antiinflammatory agents: Drugs employed in the treatment of rheumatoid arthritis and gout, in Goodman AG, Rall TW, Nies AS, et al (eds): The Pharmacological Basis of Therapeutics, 8th ed. Pergamon Press, pp 638-681, 1990.
40. Rogers J, Webster S, Lue L-F, et al: Inflammation and Alzheimer's disease pathogenesis. Neurobiol Aging 17(5): 681-686, 1996.
41. Aisen PS: Inflammation and Alzheimer's Disease. Mol Chem Neuropathol 28:83-88, 1996.
42. Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci (USA) 90:7915-7922, 1993.
43. Subbarao KV, Richardson JS, Ang LC: Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J Neurochem 55(1):342-345, 1990.
44. Sano M, Ernesto C, Thomas RG, et al: A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 336: 1216-1222, 1997.